ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Peritoneal Metastasis Clinical Trial

Official title:
Machine Learning Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Status Completed

Clinical Trial Summary

This study aimed to address the issue of peritoneal metastasis (PM) following the rupture of hepatocellular carcinoma (HCC) and its adverse impact on patient prognosis. Clinical data from 522 patients with ruptured HCC who underwent surgery at seven different medical centers were collected and analyzed. Machine learning models were employed for analysis and prediction.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06102278
Study type	Observational
Source	Tongji Hospital
Contact
Status	Completed
Phase
Start date	January 1, 2020
Completion date	April 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05544253` - Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC	Phase 2/Phase 3
Recruiting	`NCT02591667` - Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer	Phase 2
Completed	`NCT01242436` - Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ovarian Cancer and Peritoneal Metastasis	N/A
Recruiting	`NCT02779608` - The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites	Phase 2